Trial intelligence / Profile preview

FK506MR vs Prograf in Stable Liver Transplantation

NCT00619398Phase 3Completed

Sponsor
Astellas Pharma
Start
Jan 2008
Primary completion
Mar 2009
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 3 trial of tacrolimus + Wuzhi capsule in Liver transplant rejection, sponsored by Astellas Pharma. Started Jan 2008; status: completed.

02

Drugs

tacrolimus + Wuzhi capsule
03

Conditions

Liver transplant rejection

Beyond the preview

Go deeper on NCT00619398.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00619398.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call